Arianna Ferrari Christopher Coenen Armin Grunwald Arnold Sauter ...

Nuffield Council of Bioethics (2005): The ethics of research involving animals.
Nuffield Council of Bioethics: London, http://www.nuffieldbioethics.org/fileLi-
brary/pdf/RIA_Report_FINAL-opt.pdf (zuletzt aufgerufen 16/08/10).
Núñez-Mujica, G. (2006): The ethics of enhancing animals, specifically the
Great Apes, Journal of Personal Cyberconsciousness 1: 1.
O’Keeffe F.E. et al. (2008): Induction of A9 dopaminergic neurons from neural
stem cells improves motor function in an animal model of Parkinson’s disease,
Brain 131(Pt 3): 630–641.
O’Rourke K. (2002): Genetically engineering a pet? History shows it won’t be
easy, Journal of the American Veterinary Association 220(2): 147–148.
O’Connell M.J., Bachilo S.M., Huffman C.B et al. (2002): Band gap fluorescence
from individual single-walled carbon nanotubes,
Science 297(5581): 593–596.
O’Doherty, A., Ruf S., Mulligan C. et al. (2005): An aneuploid mouse strain
carrying human chromosome 21 with Down syndrome phenotypes,
Science 309: 2033–2037.
Oberdörster G. (2005): Biokinetik von Nanopartikeln: Grund zum Besorgnis?
Vortrag am 11. Oktober 2005 im BUM Bonn, http://www.dialog-nanopartikel.
de/05%20Oberdoerster.pdf (zuletzt aufgerufen am 23/07/10).
Oberdörster G. (2010): Safety assessment for nanotechnology and nanomedicine:
concepts of nanotoxicology, Journal of Internal Medicine 267(1): 89–105.
Oberdörster G., Oberdörster E., Oberdörster J. (2005): Nanotoxicology:
An Emerging Discipline evolving from studies of ultrafine particles,
Environmental Health Perspectives 113(7): 823–839.
ÖBTZ (Österreichischer Verband der Brieftaubenzüchter) (2007): Verordnung
zur Durchführung von Dopingkontrollen im Sinne des §7b, http://www.
brieftauben.at/pages/fs_mReiseDop.htm?FS_innen=Verordnung_Doping.htm
(zuletzt aufgerufen am 23/07/10).
Oddo S., Caccamo A., Shepherd J.D. et al.(2003) Triple-transgenic model of
Alzheimer’s disease with plaques and tangles: Intracellular Abeta and synaptic
dysfunction, Neuron 39(3): 409–421.
OECD (Organisation for Economic Co-operation and Development) (1996):
Intellectual Property, Technology Transfer and Genetic Resources. An OECD
Survey on Current Practices and Policies. Paris: Publications Service, OECD.
Oertel D., Grunwald A. (2006): Potenziale und Anwendungsperspektiven der
Bionik – Vorstudie (TAB-Arbeitsbericht Nr. 106), Berlin: Büro für Technikfol-
gen-Abschätzung beim Deutschen Bundestag.
Ohno M., Frankland P.W., Chen A.P. et al. (2004): Inducible, pharmacogene-
tic approaches to the study of learning and memory, Nature Neuroscience 4:
1238–1243.
Onifer S.M., Rabchevsky AG., Scheff S.W. (2007): Rat Models of Traumatic
Spinal Cord Injury to Assess Motor Recovery, ILAR Journal 48(4): 385–395.
Ono E. et al. (2006): Comparison of protection levels against pseudorabies
virus infection of transgenic mice expressing a soluble form of porcine nectin-1/
herpesvirus entry mediator C as a model for pseudorabies-resistant livestock,
Protocols of the National Academy of Science U.S.A 101: 327–330.
Ottinger M.A. et al (2006): The Rhesus Macaque as a model of human aging
and age-related disease. In: Conn M. P. (ed.) Handbook of models for human
Aging. Springer: Amsterdam, Boston: 457–468.
Ourednik V., Ourednik J., Flax J.D. et al. (2001): Segregation of human neural
stem cells in the developing primate forebrain, Science 293(5536): 1820–4.
PACE (2007): Die 10 größten Irrtümer in Sachen Polo Sport, PACE Polosport-
Magazin 01/07, http://www.polomagazin.com/polomagazin-2.html
(zuletzt aufgerufen am 23/07/10).
Palm M. et al. (2007): Differential anti-influenza activity among allelic variants
at the sus Scrofa Mx1 locus,
Journal of Interferon Cytokine Research 27: 147–156.
208 Animal Enhancement | Beiträge zur Ethik und Biotechnologie Animal Enhancement | Beiträge zur Ethik und Biotechnologie
209